Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
septic shock
Biotech
Abionyx hails septic success without dishing data behind claims
With the biotech yet to share numbers from the study, it is unclear if the mimic of HDL cholesterol has a future in the treatment of septic patients.
Nick Paul Taylor
Jan 17, 2023 5:30am
Inotrem sparks hope with new phase 2b data
Oct 13, 2022 12:20pm
BARDA taps Beckman Coulter to develop a blood test for MIS-C
Oct 16, 2020 12:26pm
Roche, Inotrem extend collaboration on septic shock test
Jan 21, 2020 11:50am
Leading BioSciences GI drug reduces post-heart surgery hospital stay
Jun 19, 2018 9:50am
La Jolla posts mixed bag of phase 3 data
May 22, 2017 5:04am
